UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057430
Receipt number R000065622
Scientific Title A randomized controlled trial evaluating the effectiveness of .b, a mindfulness program for adolescents, among parents and teachers.
Date of disclosure of the study information 2025/03/28
Last modified on 2026/03/09 11:50:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized controlled trial evaluating the effectiveness of .b (Dot Be), a mindfulness program for adolescents, among parents and teachers.

Acronym

Evaluating the effectiveness of .b among parents and teachers.

Scientific Title

A randomized controlled trial evaluating the effectiveness of .b, a mindfulness program for adolescents, among parents and teachers.

Scientific Title:Acronym

A randomized controlled trial evaluating the effectiveness of .b among parents and teachers.

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Parents and teachers who wish to participate in .b, a 9-week (10-session) mindfulness program for adolescents developed in the UK, will be randomly assigned to either an early intervention group or a waitlist control group. The effects will be exploratorily examined and compared using self-report questionnaires.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Mindfulness (Five Facet Mindfulness Questionnaire: 24-item version)

2. Self-compassion (Self-Compassion Scale: Japanese version)

3. Mood profile (Profile of Mood States 2: Japanese short form for adults)

4. Health-related quality of life (SF-12: Japanese version)

5. Perceived stress scale (Japanese 14-item version of the Perceived Stress Scale)

6. Parent-child relationship scale (TBD)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

.b program

Interventions/Control_2

Waitlist control group

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Individuals who wish to participate after attending the introduction session

2. Individuals who can attend at least 7 out of the 9 weekly one-hour sessions following the introduction

3. Individuals willing to engage in approximately 10 minutes of home practice on at least 6 out of 7 days each week

4. Individuals who consent to completing questionnaires before and after the program, and agree to the possibility of their anonymized data being published under data protection regulations

Key exclusion criteria

1. Individuals who have previously participated in an 8-week mindfulness program

2. Individuals with conditions such as social anxiety that may interfere with participation

3. Individuals deemed unsuitable as research participants by the principal investigator for other reasons

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Yasushi
Middle name
Last name Ito

Organization

Kansai Medical University

Division name

Department of Psychosomatic Medicine

Zip code

573-1010

Address

Kansai Medical University, 2-5-1 Shinmachi, Hirakata City.

TEL

072-804-0101

Email

edu@mbsrjapan.com


Public contact

Name of contact person

1st name Yasushi
Middle name
Last name Ito

Organization

Kansai Medical University

Division name

Department of Psychosomatic Medicine

Zip code

573-1010

Address

Kansai Medical University, 2-5-1 Shinmachi, Hirakata City.

TEL

072-804-0101

Homepage URL


Email

edu@mbsrjapan.com


Sponsor or person

Institute

Kansai Medical University

Institute

Department

Personal name



Funding Source

Organization

Others

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Shiga University, Osaka University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Medical University

Address

2-5-1 Shinmachi, Hirakata City.

Tel

072-804-2440

Email

rinriirb@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

YES

Study ID_1

2024312

Org. issuing International ID_1

Kansai Medical University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 03 Month 28 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

96

Results

89 participants were included in the analysis. In the .b group, significant improvements were observed in all measures except PS Laxness (paired t-tests), with effect sizes ranging from small to large (Hedges'g = .35 to .79). No significant changes were observed in the waitlist group. Post-intervention ANCOVA revealed that the .b group showed significantly greater improvements than the waitlist group on all measures except mental health-related QOL and PS, with small-to-large effect sizes.



Results date posted

2026 Year 03 Month 09 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2026 Year 03 Month 07 Day

Baseline Characteristics

Parents and teachers without significant physical or psychiatric disorders were recruited via the internet. After providing informed consent, participants were randomly assigned to either the .b group (n = 48; 7 teachers) or a waitlist control group (n = 48; 6 teachers).The mean age was 46.4 years (SD = 6.0); 94.4% were female, and 85.4% participated as parents. No significant between-group differences were found in demographic or baseline variables.

Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 03 Month 19 Day

Date of IRB

2025 Year 03 Month 18 Day

Anticipated trial start date

2025 Year 04 Month 14 Day

Last follow-up date

2026 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 03 Month 27 Day

Last modified on

2026 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065622